Trial reportDiabetes, obesity & metabolism2026
Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes.
Trial report in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06419907 (A Feasibility Study Evaluating the Impact of Differing Completion Rates of a Face-to-face Diabetes Self-management Education Programme on Patient Reported Outcome Measures.), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Feasibility Study Evaluating the Impact of Differing Completion Rates of a Face-to-face Diabetes Self-management Education Programme on Patient Reported Outcome Measures.
Who cites it
1 citing paper in PubMed.
- Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes.Diabetes, obesity & metabolism · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo examine the dose-response relationship between diabetes self-management education (DSME) attendance and psychological outcomes in type 2 diabetes, assessing whether minimal attendance (10%) produces clinically meaningful improvements and comparing outcomes at the internationally adopted 60% completion benchmark with full (100%) completion. MATERIALS AND
methodsThis randomised feasibility trial enrolled 120 adults (≥ 18 years) due to attend a UK DSME programme. Participants were randomised to receive 100% (routine DSME), 60%, 10% or 0% (delayed DSME). Primary outcomes were changes in self-management skills; secondary outcomes included health-related quality of life (HRQoL) and diabetes distress.
resultsParticipants had a mean age of 61 years, mean HbA
conclusionsIn this randomised feasibility trial, clinically significant psychological benefits from DSME required full (100%) programme completion. Attendance thresholds of ≤ 10% or partial completion (≥ 60%) did not yield meaningful improvements in diabetes distress or HRQoL. These findings suggest that existing performance indicators based on partial attendance may not reflect meaningful benefits and support 100% DSME attendance as the gold standard.
trial registrationClinicaltrials.gov identifier: NCT06419907.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.